I am a Medical Oncologist since 2013 and have had an academic position as the head of a department in a University Hospital for five years. My clinical specialties are urologic and gynecologic cancers. I enrolled in more than 20 phases 2 and 3 trials as a PI/SubI with many companies (eg: MSD; AstraZeneca, Roche, Novartis, Takeda.), which most of the trials were about immunotherapies and new targeted therapies. Between 2016 and 2017, for a year, I had an opportunity to join Professor Torchlin’s laboratory at the Northeastern University, Center For Pharmaceutical Biotechnology And Nanomedicine-B...
I am a Medical Oncologist since 2013 and have had an academic position as the head of a department in a University Hospital for five years. My clinical specialties are urologic and gynecologic cancers. I enrolled in more than 20 phases 2 and 3 trials as a PI/SubI with many companies (eg: MSD; AstraZeneca, Roche, Novartis, Takeda.), which most of the trials were about immunotherapies and new targeted therapies. Between 2016 and 2017, for a year, I had an opportunity to join Professor Torchlin’s laboratory at the Northeastern University, Center For Pharmaceutical Biotechnology And Nanomedicine-Boston-MA. I worked between the period of 2015-2021 at Sakarya University.